Crisis Digest

Top walking apps to track your progress and stay in shape with daily steps and routes.

Allswell raises $7M to enhance LGBTQ+ mental health services, offering virtual therapy, group programs, and trauma-informed care.

Pharma commercial teams are leveraging digital health strategies to transform operations beyond incremental AI-driven efficiency gains in call planning and repo

Biotech firm TRexBio raises $116M for a novel autoimmune therapy approach targeting regulatory T cells to restore immune balance.

The Medicare drug rebate model, known as GLOBE, cuts savings to $80 million annually, significantly altering premiums and impacting beneficiaries.

Individuals with sleep apnea face 3.62 times higher risk of developing fatty liver disease, according to a recent study.

FDA approves Teva’s first denosumab biosimilar, Degevma, for cancer bone complications in adults and adolescents, matching Xgeva’s safety and efficacy profiles.

Pharm.D. Jeff Dunn explains how the proposed 340B rebate model may add new burdens for health systems and employers in the 2026 pilot project.

EU demands stronger immunisation policies for chronic illness patients, urging better vaccine coverage to prevent complications and save lives.

Protect neurons and avoid memory loss by adding mushrooms to your daily diet, as shown in a ten-year study of over 3,100 adults.